Zai Lab (ZLAB) Liabilities and Shareholders Equity (2016 - 2026)

Zai Lab has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $1.1 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.1 billion, down 6.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 billion (up 5.99% YoY), and the FY2025 annual result was $1.2 billion, down 1.13% from the prior year.
• Liabilities and Shareholders Equity came in at $1.1 billion for Q1 2026 at Zai Lab, down from $1.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.5 billion in Q1 2022 to a low of $985.3 million in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $1.2 billion (2025), against an average of $1.2 billion.
• Peak annual rise in Liabilities and Shareholders Equity reached 32.67% in 2022, while the deepest fall reached 25.14% in 2022.
• Zai Lab's Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then declined by 15.07% to $1.0 billion in 2023, then climbed by 14.42% to $1.2 billion in 2024, then slipped by 1.13% to $1.2 billion in 2025, then retreated by 6.54% to $1.1 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.